📰 Financial Code News
Page 7 - Financial Code News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Financial Code. Real-time updates on events, politics, business and more.
December 20, 2023
To keep you informed of recent activities, below are several of the most significant federal and state events that have influenced the Consumer Financial Services industry over the past...
November 28, 2023
28.11.2023 - UBISOFT ANNOUNCES THE SUCCESS OF ITS OFFERING OF BONDS CONVERTIBLE INTO AND/OR EXCHANGEABLE FOR NEW OR EXISTING SHARES (“OCEANES”) DUE 2031 FOR A NOMINAL AMOUNT OF €494.5 MILLION 20231127 - Pricing PR (ENG) Paris, 28 November 2023 Ubisoft ...
November 28, 2023
UBISOFT ANNOUNCES THE RESULTS OF THE REPURCHASE OF ITS OUTSTANDING OCEANES DUE 24 SEPTEMBER 2024 FOR A NOMINAL AMOUNT OF APPROXIMATELY €250 MILLION 20231128 - Repurchase Pricing PR Paris, 28...
November 27, 2023
UBISOFT LAUNCHES AN OFFERING OF BONDS CONVERTIBLE INTO AND/OR EXCHANGEABLE FOR NEW OR EXISTING SHARES DUE 2031 FOR A NOMINAL AMOUNT OF APPROXIMATELY €500 MILLION AND A CONCURRENT PARTIAL REPURCHASE...
November 22, 2023
Important : Avant dexercer votre choix, veuillez prendre connaissance des instructions situées au verso - Important : Before selecting please refer to instructions on...
November 21, 2023
Abivax announces the resumption of its liquidity contract Paris, France, November 21, 2023 – 8:30 a.m. CET – Abivax SA (NASDAQ:ABVX) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on
November 21, 2023
Abivax announces the resumption of its liquidity contract Paris, France, November 21, 2023 – 8:30 a.m. CET – Abivax SA (Euronext Paris and Nasdaq: ABVX)...
November 7, 2023
BONDUELLE Head office: La Woestyne - 59173 Renescure - France A French S.C.A with a capital of 57 102 699,50 euros Registered under number : 447 250 044 Villeneuve d’Ascq, November...
November 7, 2023
PARIS and CAMBRIDGE, Mass., Nov. 07, 2023 -- NANOBIOTIX , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer,...
November 6, 2023
PARIS and CAMBRIDGE, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical...